Mera-med.ru

Онкология
- Лечение онкологии
- Меланома
- Лейкоз
- Острый лейкоз
- Хронический лейкоз
- Лейкоз крови
- Рак



















онкология рак шейки матки

The data of the first intermediate analysis of results of research BCRIG01 are published, in which comparison of efficiency of standard mode FAC (500/50/500) with a таксан-containing mode (with inclusion Таксотера) ТАС (75/50/500 (1) is lead{carried out}. Both modes were used with an interval of 3 weeks in quantity{amount} of 6 rates. This first published research estimating a role доцетаксела (Таксотера) in адъювантной of therapy of a cancer dairy железы. Earlier in two other researches (С9344 and В30) the role паклитаксела has been investigated, and one of them (С9344) has shown increase безрецидивной and the general{common} survival rate at patients with рецептороотрицательными tumours at use паклитаксела is consecutive with a mode the EXPERT. Подробнее...

It is possible to offer two explanations of this phenomenon. First, quality of performance циторедуктивных operations therefore the sizes of residual formations{educations} and volume of residual tumoral weight after performance of operative intervention were essentially reduced has improved. The second reason is connected with the advent of the new antineoplastic preparations possessing activity at a cancer яичников. To such preparations concern, in particular, таксаны (паклитаксел and доцетаксел). Подробнее...